# Correlation Between Plasma- and Endothelial DPP-4 Activity

> **NCT02192853** · PHASE4 · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** sitagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02192853
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192853, "Correlation Between Plasma- and Endothelial DPP-4 Activity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02192853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
